Fate Therapeutics, Inc.

NasdaqGM:FATE Stock Report

Market Cap: US$371.1m

Fate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:FATE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Jan 24SellUS$62,889J. WolchkoIndividual14,391US$4.37
09 Jan 24SellUS$47,519Cindy TahlIndividual10,874US$4.37
09 Jan 24SellUS$49,367Bahram ValamehrIndividual11,271US$4.38
09 Jan 24SellUS$30,712Edward DulacIndividual7,028US$4.37
26 Dec 23BuyUS$6,324,000Redmile Group, LLCCompany1,700,000US$3.72
26 Dec 23BuyUS$166,024Redmile Group, LLCCompany44,630US$3.72
18 Aug 23SellUS$13,210Edward DulacIndividual4,718US$2.80
05 Jul 23SellUS$18,769Brian PowlIndividual3,854US$4.87

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of FATE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies298,2010.238%
Individual Insiders1,669,7801.33%
VC/PE Firms8,215,9106.54%
Hedge Funds13,169,05710.5%
Institutions102,177,61681.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.7%.


Top Shareholders

Top 25 shareholders own 86.86% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.6%
Redmile Group, LLC
13,169,057US$42.9m0%2.23%
8.71%
The Vanguard Group, Inc.
9,911,007US$32.3m6.65%no data
7.99%
BlackRock, Inc.
9,099,951US$29.7m-18.8%no data
7.22%
Tavistock Life Sciences
8,215,910US$26.8m1,540%1.66%
7.06%
State Street Global Advisors, Inc.
8,036,669US$26.2m332%no data
4.9%
Deep Track Capital, LP
5,572,607US$18.2m0%0.6%
4.25%
Bellevue Asset Management AG
4,839,779US$15.8m-0.24%0.21%
2.97%
Johnson & Johnson Innovation - JJDC, Inc.
3,379,064US$11.0m0%3.76%
2.75%
Citadel Advisors LLC
3,131,526US$10.2m17.5%0.01%
2.49%
Morgan Stanley, Investment Banking and Brokerage Investments
2,835,326US$9.2m158%no data
2.4%
D. E. Shaw & Co., L.P.
2,730,966US$8.9m-23.8%0.01%
2.25%
Suvretta Capital Management, LLC
2,562,852US$8.4m0%0.42%
2.24%
Assenagon Asset Management S.A.
2,548,304US$8.3m1,460%0.02%
2.22%
Holocene Advisors, LP
2,527,747US$8.2m0%0.04%
1.92%
Deerfield Management Company, L.P. Series C
2,190,408US$7.1m0%0.16%
1.88%
Adage Capital Management, L.P.
2,140,000US$7.0m25.9%0.02%
1.76%
Jacobs Levy Equity Management Inc
1,999,822US$6.5m-23.6%0.03%
1.69%
Bank of America Corporation, Asset Management Arm
1,919,427US$6.3m217%no data
1.67%
Geode Capital Management, LLC
1,905,983US$6.2m2.28%no data
1.66%
Woodline Partners LP
1,892,002US$6.2m391%0.07%
1.6%
Baker Bros. Advisors LP
1,818,181US$5.9m0%0.08%
1.51%
Acadian Asset Management LLC
1,714,124US$5.6m-24.9%0.02%
1.42%
Goldman Sachs Group, Investment Banking and Securities Investments
1,613,695US$5.3m283%no data
1.39%
Point72 Asset Management, L.P.
1,584,300US$5.2m-57.9%0.01%
1.35%
JP Morgan Asset Management
1,536,050US$5.0m-5.48%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.